INS and metabolic dysfunction-associated steatotic liver disease: After excluding participants with a BMI < 18.5 kg/m2, the associations of both elevated FLI and total ketone bodies with all‐cause mortality remained significant except for an NAFLD model adjusted for glucose, insulin and use of glucose‐lowering drugs (Table S15).